Changes of serum markers of hepatic fibrosis after interferon treatment of patients with chronic hepatitis C

Mie Medical Journal

Volumn 48, Issue 1-3, 1998, Pages 19-25

  Ohashi, Yohei ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Hyaluronic acid; Interferon; PIIIP; Type IV collagen

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN TYPE 4; HYALURONIC ACID; INTERFERON;

ARTICLE; DISEASE SEVERITY; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; LIVER REGENERATION; MAJOR CLINICAL STUDY; PREDICTION;

EID: 0032471167     PISSN: 00263532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Clement B, Loreal O, Levavasseur F, Guillouzo A. New challenges in hepatic fibrosis. J Hepat 1993; 18: 1-4.
2. Gallorini A, Plebani M, Pontisso P, Chemello L, Masiero M, Mantovani G, Alberti A. Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2a interferon. Liver 1994; 14: 257-264.
3. Greenwel P, Geerts A, Ogata I, Solis-Herruzo J, Rojkind M. Liver fibrosis. The Liver: Biology and Pathobiology, Third Edition 1994; 72: 1367-1381.
4. Suou T, Hosho, K, Kishimoto Y, Horie Y, Kawasaki H. Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1995; 22: 426-431.
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
6. Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, Sandre GD. α-interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepat 1993; 18: 112-118.
7. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, Minetoma T, Kimura Y, Ohira H, Sata M, Yoshida H, Tanikawa K. Serum hyaluronates reflects hepatic sinusoidal capillarization. Gastroenterology 1993; 105: 475-481.
8. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994; 20: 780-787.
9. Diodati G, Bonetti P, Noventa F, Casarin C, Rugge M, Scaccabarozzi S, Tagger A, Pollice L, Tremolada F, Davite C, Realdi G, Ruol A. Treatment of chronic hepatitis C with recombinant human interferon α-2a: results of a randomized controlled clinical trail. Hepatology 1994; 19: 1-5.
10. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
11. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215-222.
12. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5'non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661-668.
13. Tsubota A, Chayama, K, Ikeda K, Arase Y, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Kumada H. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-1094.
14. Teran JC, Mullen KD, Hoofnagle JH, McCullough AJ. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-α. Hepatology 1994; 19: 849-856.
15. McCullough AJ, Stassen WN, Wiesner RH, Czaja AJ. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology 1987; 7: 49-54.
16. Deaciuc IV, Bagby GJ, Lang CH, Spitzer JJ. Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology 1993; 17: 266-272.
17. Matsuzaki Y, Yoshiga S, Sugitani T, Shoda J, Tanaka N, Osuga T. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases. Clin Chim Acta 1993; 221: 209-217.
18. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984; 74: 1112-1116.
19. Hayashi A, Kohen H, Yoshikawa N, Iida S, Ohto M. The effect of interferon alfa and prednisolone on the serum concentrations of the aminoterminal domain of procollagen type III (P-III-P) and type IV (7-S collagen) in patients with chronic hepatitis B. J Hepat 1993; 19: 36-42.
20. Hoofnagle, JH, Mullen KD, Jones B, Rustgi V, Bisceglie AD, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986; 315: 1575-1578.
21. Ueno T, Inuzuka S, Sata M, Koh H, Tamaki S, Kin M, Sugawara H, Sakata R, Torimura T, Tanikawa K. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C. Hepato-Gastroenterol 1995; 42: 522-527.
22. Yabu K, Kiyosawa K, Mori H, Matsumoto A, Yoshizawa K, Tanaka E, Furuta S. Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol 1994; 29: 474-479.
23. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of α-interferon therapy. J Hepatol 1995; 22: 22-26.
24. Trinchet JC. Clinical use of serum markers of fibrosis in chronic hepatitis. J Hepatol 1995; 22 (Suppl. 2): 89-95.
25. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaud JA. Interferon-α 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepatology 1993; 18: 1344-1349.